Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellen was a UK healthcare company focused on chronic pain management through an integrated digital clinic model. The business combined clinical care, research, and innovation tools, with a particular emphasis on improving access to non-opioid pain treatments, including medical cannabis products in the UK. Publicly available descriptions portray Cellen as an online chronic pain clinic serving patients through multidisciplinary care and technology-enabled services rather than as a traditional drug-development biotech with a disclosed therapeutic pipeline. The company appears to have operated commercially but later entered administration, and third-party databases now describe it as closed. As a result, Cellen is best characterized as a healthtech-enabled pain management and medical cannabis access company rather than a conventional therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellen Life Sciences.